Theralase Launches Fourth Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study
TORONTO, ON / ACCESSWIRE / January 27, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT) (OTCQB:TLTFF), a clinical stage...